Moreover, systemic inflammation in patients with psoriasis, including elevated serum proinflammatory cytokines (e.g.,TNF-α, IL-17, and IL-23) may contribute to an increased risk of atherosclerosis, hypertension, alteration of serum lipid composition, and IR (20). This evidence concerns the gene IL17A and psoriasis.